COVID Catalyst Awardees Announced!   Congratulations to our Covid Catalyst awardees for being selected for bridge funding for their high-risk, innovative, and important research on the Covid-19 pandemic. Awardees by institution: UC Berkeley Kunxin Luo – High affinity soluble ACE2 decoy receptor approach for Covid-19             Russell Vance –  Targeting the inflammasome

CEND investigator Dr. Eva Harris and collaborators from the National Autonomous University of Nicaragua, Emory University, University of North Carolina at Chapel Hill, UC Berkeley, published their serologic surveillance findings of maternal Zika infection on Leon, Nicaragua, which found that 20% of pregnant women were infected at the peace of the epidemic. Read the full

Extracted from the New York Times on January 1st, 2019:   In Japan, a tour bus driver in his 60s who had driven two different groups from Wuhan, China, was confirmed to have the coronavirus, officials said on Tuesday. The driver had no history of traveling to Wuhan, the epicenter of the outbreak. “I think

CEND Investigator Dr. Lee Riley and lab members Julia Rubin, Kaitlyn Mussio, Yaqi Xu, and Joy Suh recently published their paper Prevalence of Antimicrobial Resistance Genes and Integrons in Commensal Gram-Negative Bacteria in a Community College in the journal Microbial Drug Resistance. Abstract Although the human intestinal microbiome has been shown to harbor antimicrobial drug resistance genes

The National Institute of Health has awarded the UC Berkeley School of Public Health with $3.8 million to research the emergence of Valley Fever, also known as coccidioidomycosis, or “cocci”. This research will be spearheaded by the lab of Dr. Justin Remais, CEND investigator and Head of Environmental Health Sciences at the UC Berkeley School of

Unexpectedly, disease severity and high transmission rates go hand-in-hand. Read more about Dr. Harris’ findings here.

CEND Investigator Britt Glausinger, a virologist in the Department of Plant and Microbial Biology, and her team study the tactics that gammaherpesviruses use to manipulate gene expression in host cells during infection. Learn more about her work and findings in BREAKTHROUGHS: The Magazine of the College of Natural Resources. Featured image taken by Elena Zhukova

Great new work from CEND faculty Dan Fletcher and 2019 CEND symposium speaker Thomas Nutman together with collaborators in Cameroon providing evidence-based strategies to treat river blindness, a parasitic worm infection. You can read the abstract on their work here.

CEND Fellow Cara Brook and collaborators from the Pasteur Institut Madagascar and Princeton University are featured on the Gates Foundation Website for their Gates Grand Challenges project on metagenomics and the etiology of zoonotic disease. Read more about their project here.

Faculty David Raulet and Aduro Biotech Collaborators published their research, SLC19A1 transports immunoreactive cyclic dinucleotides, in Nature on September 11, 2019. This research has landmark implications for immunotherapeutic treatment of cancer, host responsiveness to CDN-producing pathogenic microorganisms, and possibly for some inflammatory diseases. To read the paper entirely, you can go here.